Feasibility of Patient-Reported Outcome Assessment in the Acute Phase after CAR T-Cell Therapy in Lymphoid Malignancies: A Pilot Study

Chakraborty, R., Behera, T. R., Li, H., Dean, R. M., Hill, B. T., Jagadeesh, D., Winter, A., Anwer, F., Pohlman, B., Sobecks, R. M., Hamilton, B. K., & Majhail, N. S. (2022). Feasibility of Patient-Reported Outcome Assessment in the Acute Phase after CAR T-Cell Therapy in Lymphoid Malignancies: A Pilot Study. Blood, 140(Supplement 1), 10926–10927. https://doi.org/10.1182/blood-2022-166904
Authors:
Rajshekhar Chakraborty
Tapas Ranjan Behera
Hong Li
Robert M. Dean
Brian T. Hill
Deepa Jagadeesh
Allison Winter
Faiz Anwer
Brad Pohlman
Ronald Sobecks
Betty K. Hamilton
Navneet S. Majhail
Affiliated Authors:
Rajshekhar Chakraborty
Columbia Affiliation:
Subjects:
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2022-166904
DOI:
10.1182/blood-2022-166904
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: